Development of the Chronic Sialadenitis Outcome Test‐14 for Chronic Sialadenitis
The Laryngoscope · 2026
DOI: 10.1002/lary.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Juha Vartiainen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Päijät-Häme Central Hospital, Lahti, Finland. Hauptthemen laut MEDLINE: Sialadenitis, Quality of Life. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The State Research Funding, Helsingin ja Uudenmaan Sairaanhoitopiiri.
Abstract (Originalsprache)
Objective
Patient perspectives have become an important aspect of healthcare evaluation. To measure health related quality of life (HRQoL), it is essential to apply well‐researched HRQoL instruments. Current instruments for chronic sialadenitis have limitations and, thus, we created a new disease‐specific HRQoL tailored for chronic sialadenitis.
Methods
COSMIN guidelines were followed. Initially, a preliminary 24‐item questionnaire was created. Untreated patients ( n = 126) were recruited to complete the preliminary questionnaire alongside the generic HRQoL instrument, 15D. ENT specialists evaluated the severity of the disease and the disability caused by the disease. Additionally, a control group of healthy adults was recruited for comparison. Based on patients' responses, items were reduced using predefined criteria, and the final instrument was validated with statistical analyses. Cronbach's α was used to measure internal consistency, and the intraclass correlation coefficient (ICC) was used to measure test–retest reliability.
Results
The most suitable recall period was 3 months. With statistical analyses, the number of items was reduced to 14, leading to the creation of the final instrument, the Chronic Sialadenitis Outcome Test 14, CSOT‐14. CSOT‐14 had good internal consistency (Cronbach's α = 0.871) and test–retest reliability (ICC = 0.911), and it differentiated patients from healthy controls.
Conclusions
A novel instrument for chronic sialadenitis, CSOT‐14, that clearly differentiated patients from healthy controls was created and validated. The instrument can be used in daily clinical practice for patients with chronic sialadenitis. Level of Evidence 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Päijät-Häme Central Hospital, Lahti, Finland.
- Department of Otorhinolaryngology-Head and Neck Surgery, Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Otorhinolaryngology-Head and Neck Surgery, Kuopio University Hospital and University of Kuopio, Kuopio, Finland.
- Department of Otorhinolaryngology, Hospital Nova of Central Finland, Jyväskylä, Finland.
ORCID-Profile: Juha Vartiainen, Aaro Haapaniemi
Förderung
- The State Research Funding
- Helsingin ja Uudenmaan Sairaanhoitopiiri
Zitieren
APA
Vartiainen, J., Saarinen, R., Laakso, J., Jokela, J., Haaramo, A., Haapaniemi, A., Dietz, A., & Sinkkonen, S. T. (2026). Development of the Chronic Sialadenitis Outcome Test‐14 for Chronic Sialadenitis. The Laryngoscope. https://doi.org/10.1002/lary.70003
Vancouver
Vartiainen J, Saarinen R, Laakso J, Jokela J, Haaramo A, Haapaniemi A, et al. Development of the Chronic Sialadenitis Outcome Test‐14 for Chronic Sialadenitis. The Laryngoscope. 2026. doi:10.1002/lary.70003
BibTeX
@article{Vartiainen2026,
author = {Vartiainen, Juha and Saarinen, Riitta and Laakso, Juha and Jokela, Johanna and Haaramo, Anu and Haapaniemi, Aaro and Dietz, Aarno and Sinkkonen, Saku T},
title = {Development of the Chronic Sialadenitis Outcome Test‐14 for Chronic Sialadenitis},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70003}
}
EUVIMED